Compare STEP & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STEP | RDNT |
|---|---|---|
| Founded | 2007 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.7B |
| IPO Year | 2020 | 1986 |
| Metric | STEP | RDNT |
|---|---|---|
| Price | $62.43 | $69.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $76.71 | ★ $86.00 |
| AVG Volume (30 Days) | 661.0K | ★ 661.3K |
| Earning Date | 02-05-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,535,264,000.00 | ★ $1,969,599,000.00 |
| Revenue This Year | N/A | $11.82 |
| Revenue Next Year | $27.26 | $11.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 91.84 | 11.09 |
| 52 Week Low | $40.07 | $45.00 |
| 52 Week High | $77.80 | $85.84 |
| Indicator | STEP | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 29.58 | 38.37 |
| Support Level | $71.44 | $69.40 |
| Resistance Level | $74.65 | $74.16 |
| Average True Range (ATR) | 2.92 | 2.60 |
| MACD | -1.32 | -0.26 |
| Stochastic Oscillator | 3.49 | 8.72 |
StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.